2026-

  1. "Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia"
    Wacharapluesadee S, Saikruang W, Lytras S, Matsumoto K, Uriu K, Hinay A Jr, Guo Z, Rattanatumhi K, Supataragul A, Ninwattana S, Thippamom N, Srisuk T, Maneeorn P, Noradechanon K, Duengkae P, Sirichan N, Kosugi Y, Fujita S, Yo MS, Matsunaga R, Hu B, Du L, Wang L, Tsuda M, Oda Y, Nasser H, Kimura KT, Akasaka H, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Yamamoto Y, Nagamoto T, Asakura T, Shihoya W, Hashiguchi T, Ikeda T, Tanaka S, Chu H, Tsumoto K, Nureki O; Genotype to Phenotype Japan (G2P-Japan) Consortium; Genotype to Phenotype Asia (G2P-Asia) Consortium; Plianchaisuk A, Putcharoen O, Sato K.,
    Cell, S0092-8674(26)00454-X (2026).
  2. "Engineering a compact high-fidelity Staphylococcus aureus Cas9 variant with broader targeting range and mechanistic insights into its activation"
    Omura SN, Nakagawa R, Kajimoto S, Okazaki S, Ishiguro S, Mori H, Onishi K, Kashiwakura Y, Hiramoto T, Horinaka K, Tanaka M, Hirano H, Jividen K, Yamashita K, Tsai SQ, Yachie N, Ohmori T, Nishimasu H, Nureki O,
    Nature commun, 17(1) 3584 (2026).
  3. "Structural insights into inhibition mechanism of the helicase-primase complex from human herpesvirus 1"
    Sato K, Ishida H, Miyagishi T, Kobayashi S, Kise Y, Hamada K, Okada C, Oguni A, Nureki O, Kono H, Fukuzawa K, Sengoku T,
    Cell Chem Biol, S2451-9456(26)00076-0 (2026).
  4. "Structural basis for DNA processing and membrane translocation by ComEC in natural transformation"
    Hirano H, Tsuji N, Chiba S, Nureki O,
    Science, 392(6795) 311-316 (2026).
  5. "HUH-tagged Cas9 as a platform for efficient ssODN-mediated knock-in via embryo and adult injection in insects"
    Shirai Y, Kao JA, Kumar T, Matsuda N, Nakagawa R, Nureki O, Extavour CG, Daimon T,
    Commun Biol, 9(1) 514 (2026).
  6. "Molecular mechanism of MDA5 nucleation and filament formation by LGP2"
    Kurihara N, Isayama Y, Zhang J, Yamashita T, Awaji K, Ito Y, Yoshizaki A, Kouwaki T, Oshiumi H, Nishimasu H, Shibata M, Nureki O, Kato K,
    Mol Cell, 86(4) 707-721 (2026).
  7. "Efficient and accurate prime editing system in plants"
    Nishizawa-Yokoi A, Iida K, Mori A, Takemura M, Shuto Y, Nakagawa R, Nureki O, Toki S,
    New Phytol, 249(5) 2163-2172 (2026).
  8. "Photoaffinity Labeling Strategy Reveals Tetraspanin CD9 as a Transient Target of Anticancer Yaku'amide B"
    Fu J, Kamiya K, Kitamura K, Kawahara R, Shihoya W, Nureki O, Hosoya S, Nakagawa R, Mashima T, Itoh H, Inoue M, Sakurai K,
    J Am Chem Soc, 148(3) 2985-2994 (2026).
  9. "Structure and evolution of the sequence-specific anti-silencing factor VANC21 and its target DNA"
    Tanaka Y, Osakabe A, Shihoya W, Hirano H, Itoh Y, Kakutani T, Nureki O,
    Genes Genet Syst, 101 (2026).
  10. "Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy"
    Kashiwakura Y, Nakajima Y, Horinaka K, Lopes TJS, Furuta Y, Yamaguchi Y, Baatartsogt N, Hayakawa M, Katakai Y, Uchiyama S, Nureki O, Nogami K, Ohmori T,
    Blood, 147(4) 402-415 (2026).
  11. "Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia B"
    Baatartsogt N, Kashiwakura Y, Hiramoto T, Ito R, Sato R, Nagao Y, Naruoka H, Takata H, Hayakawa M, Batjargal K, Togashi T, Hoshino A, Shimizu T, Sato Y, Ishida T, Nureki O, Ohmori T,
    Blood, 147(7) 458-470 (2026).